NasdaqGM - Delayed Quote USD

Centogene N.V. (CNTG)

0.4610 -0.0100 (-2.12%)
At close: April 18 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Kim Stratton CEO & Member of Management Board 918.58k -- 1962
Mr. Jose Miguel Coego Rios CFO, Legal & IT and Member of Management Board 319k -- --
Dr. Peter Bauer M.D. Chief Medical & Genomic Officer and Member of Management Board 183.5k -- 1970
Dr. Andrin Oswald M.D., Ph.D. Advisor 929.25k -- 1972
Mr. Ian Rentsch Chief Commercial Officer & GM of Pharma -- -- --

Centogene N.V.

Am Strande 7
Rostock, 18055
Germany
49 381 80113 500 https://www.centogene.com
Sector: 
Healthcare
Full Time Employees: 
444

Description

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Corporate Governance

Centogene N.V.’s ISS Governance QualityScore as of April 1, 2024 is 7. The pillar scores are Audit: 4; Board: 6; Shareholder Rights: 5; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 14, 2024 - May 20, 2024
Centogene N.V. Earnings Call

Related Tickers

XGN Exagen Inc.
1.4289
+2.06%
 
MYNZ Mainz Biomed N.V.
0.9040
-2.92%
 
MYGN Myriad Genetics, Inc.
18.51
-0.70%
 
NDRA ENDRA Life Sciences Inc.
0.2334
+2.32%
 
ISPC iSpecimen Inc.
0.4210
+97.65%
 
PMD Psychemedics Corporation
2.5600
-1.54%
 
APDN Applied DNA Sciences, Inc.
0.3376
+1.38%
 
PRE Prenetics Global Limited
3.1900
+1.27%
 
BNR Burning Rock Biotech Limited
0.8000
+4.93%
 
RVTY Revvity, Inc.
99.38
-1.09%